Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 12, 11751-11763
- https://doi.org/10.2147/ott.s235667
Abstract
Introduction: Glutamine metabolism is essential for the proliferation of cancer cells. Transported by SLC1A5, a Na+ dependent transporter, glutamine is absorbed for further use. Recent studies have revealed the anti-tumor effect of berberine. The present study aimed to evaluate the effect of berberine on cancer cell glutamine metabolism. Materials and methods: The inhibitory effect of berberine on liver cancer cells was analyzed by CCK-8 and EdU assay. The glutamine concentrations were detected by ELISA and UHPLC-MRM-MS analysis. Glutamine metabolism-related proteins were determined by Western blot, immunofluorescent analysis and immunohistochemistry. Results: Berberine inhibited the proliferation of Hep3B and BEL-7404 cell in vitro. Berberine suppressed the glutamine uptake by inhibiting SLC1A5. The upregulation of SLC1A5 led to an increased glutamine uptake and improved tolerance to berberine. Berberine suppresses SLC1A5 expression by inhibiting c-Myc. Furthermore, berberine suppresses the growth of tumor xenografts, and the expression of SLC1A5 and c-Myc in vivo. The high expression of SLC1A5 in hepatocellular carcinoma (HCC) tissues is associated with poor prognosis. Conclusion: Berberine can suppress the proliferation of liver cancer cells by reducing SLC1A5 expression.Keywords
This publication has 37 references indexed in Scilit:
- Goals and targets for personalized therapy for HCCHepatology International, 2019
- Effects of berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targetsBiomedicine & Pharmacotherapy, 2018
- Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2Biomedicine & Pharmacotherapy, 2018
- An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models2018
- Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular CarcinomaDigestion, 2017
- Cancer cell metabolism: the essential role of the nonessential amino acid, glutamineThe EMBO Journal, 2017
- A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesisHepatology, 2017
- Modulation of oxidative stress as an anticancer strategyNature Reviews Drug Discovery, 2013
- Nutrient transporters: the Achilles’ heel of anabolismTrends in Endocrinology & Metabolism, 2013
- Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses.1982